Hellstrom PM, et al
CrossRef Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases Ghadeer Alhamar, Joanna Razafiarison, Fawaz Alzaid, Fahd AlMulla, Rasheed Ahmad Obesity Reviews .2026;[Epub] CrossRef Cardiovascularkidneymetabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD Xiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, Seung Up Kim, Terry Cheuk-Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jrme Boursier, Elisabetta Bugianesi, Hannes Hagstrm, Wah-Kheong Chan, Manuel Romero-Gomez, Jos Luis Calleja, Victo Hepatology .2026
& Loukas, A
What the Program Covers and Who Qualifies The Medicare GLP-1 Bridge will cover certain GLP-1 medications when prescribed specifically for obesity treatment in eligible Medicare Part D beneficiaries